Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Psychol Addict Behav. 2011 Mar;25(1):127–142. doi: 10.1037/a0022350

Table 1.

Means (and standard deviations) on selected neuropsychological measures for controls and combined clinical participants over 10 years.

Measure Sample Time (years)
Intake 0.5 1 2 4 6 8 10
CVLTa
List A Trial 1 Clinical 7.5 (1.9) 7.9 (2.1) 8.7 (2.3) 8.5 (2.8) 8.2* (2.5) 7.8* (2.3) 8.1 (2.3) 6.6 (1.9)
Control 7.3 (1.7) 7.9 (2.2) 9.4 (2.5) 9.4 (2.2) 9.1* (2.2) 8.7* (2.1) 8.9 (2.3) 6.7 (1.8)
SDFR Clinical 11.7 (4.4) 12.0 (4.8) 12.7 (4.5) 12.7 (5.9) 12.4* (6.4) 12.3 (4.4) 12.0* (4.9) 11.1 (8.0)
Control 12.1 (4.4) 12.0 (6.5) 12.7 (4.3) 13.1 (4.3) 13.5* (3.6) 13.3 (3.8) 13.4* (3.1) 12.6 (6.2)
LDFR Clinical 12.1 (2.7) 12.4 (2.7) 13.1 (2.5) 12.8 (3.2) 12.8 (3.0) 12.5* (3.1) 12.4* (2.9) 11.9 (2.8)
Control 12.1 (2.8) 12.4 (3.1) 13.3 (2.6) 13.4 (2.5) 13.7 (2.4) 13.9* (2.4) 13.4* (2.9) 13.3 (2.2)
Rec. Disc. (%) Clinical 95.9 (4.4) 95.8 (4.8) 96.4 (4.5) 95.6 (5.9) 95.7 (6.4) 95.6* (4.4) 95.6* (4.9) 94.1 (8.0)
Control 95.9 (4.4) 95.5 (6.5) 97.0 (4.3) 97.2 (4.3) 97.4 (3.6) 97.5* (3.8) 97.8* (3.1) 96.2 (6.2)
Arithmeticb Clinical 10.4 (3.2) 10.5* (2.7) 10.5** (2.9) 10.0** (2.6) 9.1** (2.4) 9.2* (2.4) 9.6 (2.4) 9.8 (2.7)
Control 10.7 (3.1) 11.5* (2.5) 12.7** (3.0) 11.6** (2.9) 11.1** (2.8) 10.2* (2.7) 10.1 (2.6) 10.4 (3.0)
ROCF 30 min.c Clinical 16.3 (5.4) 15.6 (5.1)
Control 18.1 (5.3) 16.0 (5.9)
a

California Verbal Learning Test (CVLT) raw scores (List A Trial 1; SDFR=short delay free recall; LDFR=long delay free recall) and percent correct (recognition discriminability); CVLT-II administered at years 8 and 10.

b

WISC-R (baseline, 6 month, and 1 year follow-ups) and WAIS-R (years 2–10) Arithmetic age-corrected scaled scores.

c

Rey Osterrieth Complex Figure test (ROCF) 30-minute delayed recall (administered at years 8 and 10).

*

p<.05;

**

p<.01